The Top 25 Healthcare Technology Leaders of San Francisco for 2022

Share Article

The Healthcare Technology Report is pleased to announce The Top 25 Healthcare Technology Leaders of San Francisco for 2022

The Healthcare Technology Report is pleased to announce The Top 25 Healthcare Technology Leaders of San Francisco for 2022. San Francisco and the larger bay area, including Silicon Valley, is home to some of the most revolutionary healthcare technology companies in the world. Those represented on this year’s list are innovating across a wide range of specialties, from immunotherapy to blood transfusions, ultrasound ablation, vaccines, and much more. The only way such innovation is possible is with an experienced leadership team that is able to guide an organization while keeping patient well-being front of mind — and these leaders have done just that.

Some of the distinguished leaders on this year’s list include Whitney Jones, SVP and CPO of Sangamo Therapeutics, who is responsible for all things people and culture for the genomic medicine company. Meanwhile, SVP of Customer Engagement for Genentech Kate Rowbotham leads a team of roughly 1,300 employees with responsibility for the entire Genentech portfolio of medicines, delivering approximately $25 billion in annual revenue. And Grant Pickering co-founded and is CEO and Director of Vaxcyte, which is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases.

This year’s awardees lead from a variety of positions, from CEO to COO, President, VP, and Chief Information Officer. What they have in common is the transformative effects they have on their organizations, all of which in the end contribute to the success of their companies and significant improvement in the lives of patients. Please join us in celebrating The Top 25 Healthcare Technology Leaders of San Francisco for 2022.

Sri Kosaraju (Inscripta, Inc.), Andrew Allen (Gritstone Bio), Wilson Constantine (Smiths Medical), Stefani Wolff (Nurix, Inc.), William Greenman (Cerus), Whitney Jones (Sangamo Therapeutics, Inc.), Kate Rowbotham (Genentech), Hamta Podesta (Dermavant Sciences), Krish Krishnan (Krystal Biotech, Inc.), Andrew Weiss (ReCor Medical), Grant Pickering (Vaxcyte), Jeffrey Bluestone (Sonoma Biotherapeutics), Darren Platt (Demetrix), Matt Brokaw (Aerin Medical), Greg Bullington (Magnolia Medical Technologies), Sumita Ray (Instil Bio), Laurent Fischer (Adverum Biotechnologies, Inc.), Federico Vegh (Stämm Biotech), James Bullard (Pendulum Therapeutics), Amy Sehnert (Bristol Myers Squibb), Signe Haughton (Medtronic), Mark Dresser (Gilead Sciences), Pablo Gersberg (Neumora), Tony Taricco (PRC Clinical), Henry Tse (Cytovale).

The full article can be read at https://thehealthcaretechnologyreport.com/

About The Healthcare Technology Report

The Healthcare Technology Report provides market research and insights, business news, investment activity updates, and important corporate developments related to the healthcare technology sector. Based in New York City, the firm is run by a seasoned team of editors, writers, and media professionals highly knowledgeable on healthcare technology and the various companies, executives, and investors that make up the sector.

Share article on social media or email:

View article via:

Pdf Print

Contact Author